APO Research
Talk to an analyst

APO RESEARCH · REPORT

Drugs for Infectious Diseases Caused by Neisseria Gonorrhoeae

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global Drugs for Infectious Diseases Caused by Neisseria Gonorrhoeae Industry Growth and Trends Forecast to 2032

23 December 2025122 pages

Choose your research edition.

Industry ResearchDrugs for Infectious Diseases Caused by Neisseria Gonorrhoeae Industry Research Report 2026142 pages · $2,950 USDIndustry Growth & TrendsGlobal Drugs for Infectious Diseases Caused by Neisseria Gonorrhoeae Industry Growth and Trends Forecast to 2032122 pages · $3,450 USDMarket StructureGlobal Drugs for Infectious Diseases Caused by Neisseria Gonorrhoeae Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032199 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Drugs for Infectious Diseases Caused by Neisseria Gonorrhoeae Market Outlook and Growth Opportunities 2026203 pages · $4,250 USDMarket Analysis & ForecastGlobal Drugs for Infectious Diseases Caused by Neisseria Gonorrhoeae Market Analysis and Forecast 2026-2032203 pages · $4,950 USD

Market perspective

According to APO Research, the global Drugs for Infectious Diseases Caused by Neisseria Gonorrhoeae market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for Drugs for Infectious Diseases Caused by Neisseria Gonorrhoeae is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for Drugs for Infectious Diseases Caused by Neisseria Gonorrhoeae is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Drugs for Infectious Diseases Caused by Neisseria Gonorrhoeae is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global companies in the Drugs for Infectious Diseases Caused by Neisseria Gonorrhoeae market include Takeda Pharmaceutical, CSPC, Shenzhen Lijian Pharmaceutical, Sanofi, Merck & Co., Inc. (USA), Roche, Pfizer Inc. (USA), NCPC and Sinopharm Group, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global Drugs for Infectious Diseases Caused by Neisseria Gonorrhoeae market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Drugs for Infectious Diseases Caused by Neisseria Gonorrhoeae market size, estimates, and forecasts are presented in terms of revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Drugs for Infectious Diseases Caused by Neisseria Gonorrhoeae market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Drugs for Infectious Diseases Caused by Neisseria Gonorrhoeae.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading companies in the global Drugs for Infectious Diseases Caused by Neisseria Gonorrhoeae market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue and gross margin data by manufacturer for 2021-2026, enabling benchmarking of scale, profitability, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Drugs for Infectious Diseases Caused by Neisseria Gonorrhoeae Market by Company

Takeda Pharmaceutical

CSPC

Shenzhen Lijian Pharmaceutical

Sanofi

Merck & Co., Inc. (USA)

Roche

Pfizer Inc. (USA)

NCPC

Sinopharm Group

GlaxoSmithKline plc (UK)

Daiichi Sankyo

Bayer

AbbVie

Sun Pharmaceutical

Lupin

Hikma Pharmaceuticals

Dr. Reddy's Laboratories

Cipla

Celltrion

Astellas Pharma Inc. (Japan)

Drugs for Infectious Diseases Caused by Neisseria Gonorrhoeae Segment by Type

Ceftriaxone

Doxycycline

Other

Drugs for Infectious Diseases Caused by Neisseria Gonorrhoeae Segment by Application

Retail Pharmacy

Hospital

Other

Drugs for Infectious Diseases Caused by Neisseria Gonorrhoeae Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Colombia

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Drugs for Infectious Diseases Caused by Neisseria Gonorrhoeae market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Drugs for Infectious Diseases Caused by Neisseria Gonorrhoeae and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market

5. This report helps stakeholders to gain insights into which regions to target globally

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Drugs for Infectious Diseases Caused by Neisseria Gonorrhoeae.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2021-2025, 2026-2031). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 3: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 4: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 5: Detailed analysis of Drugs for Infectious Diseases Caused by Neisseria Gonorrhoeae companies' competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, revenue by country.

Chapter 12: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. Global Drugs for Infectious Diseases Caused by Neisseria Gonorrhoeae Market Size (US$ Million) Comparison by Region: 2021 VS 2025 VS 2032 Table 2. Global Drugs for Infectious Diseases Caused by Neisseria Gonorrhoeae Market Size by Region (2021-2026) & (US$ Million) Table 3. Global Drugs for Infectious Diseases Caused by Neisseria Gonorrhoeae Market Share by Region (2021-2026) Table 4. Global Drugs for Infectious Diseases Caused by Neisseria Gonorrhoeae Market Size by Region (2027-2032) & (US$ Million) Table 5. Global Drugs for Infectious Diseases Caused by Neisseria Gonorrhoeae Market Share by Region (2027-2032) Table 6. Global Drugs for Infectious Diseases Caused by Neisseria Gonorrhoeae Market Size by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 7. Global Drugs for Infectious Diseases Caused by Neisseria Gonorrhoeae Market Size by Type (2021-2026) & (US$ Million) Table 8. Global Drugs for Infectious Diseases Caused by Neisseria Gonorrhoeae Market Size Share by Type (2021-2026) Table 9. Global Drugs for Infectious Diseases Caused by Neisseria Gonorrhoeae Market Size Forecasted by Type (2027-2032) & (US$ Million) Table 10. Global Drugs for Infectious Diseases Caused by Neisseria Gonorrhoeae Market Size Share Forecasted by Type (2027-2032) Table 11. North America Drugs for Infectious Diseases Caused by Neisseria Gonorrhoeae Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 12. North America Drugs for Infectious Diseases Caused by Neisseria Gonorrhoeae Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 13. Europe Drugs for Infectious Diseases Caused by Neisseria Gonorrhoeae Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 14. Europe Drugs for Infectious Diseases Caused by Neisseria Gonorrhoeae Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 15. Asia-Pacific Drugs for Infectious Diseases Caused by Neisseria Gonorrhoeae Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 16. Asia-Pacific Drugs for Infectious Diseases Caused by Neisseria Gonorrhoeae Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 17. Latin America Drugs for Infectious Diseases Caused by Neisseria Gonorrhoeae Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 18. Latin America Drugs for Infectious Diseases Caused by Neisseria Gonorrhoeae Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 19. Middle East and Africa Drugs for Infectious Diseases Caused by Neisseria Gonorrhoeae Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 20. Middle East and Africa Drugs for Infectious Diseases Caused by Neisseria Gonorrhoeae Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 21. Global Drugs for Infectious Diseases Caused by Neisseria Gonorrhoeae Market Size by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 22. Global Drugs for Infectious Diseases Caused by Neisseria Gonorrhoeae Market Size by Application (2021-2026) & (US$ Million) Table 23. Global Drugs for Infectious Diseases Caused by Neisseria Gonorrhoeae Market Size Share by Application (2021-2026) Table 24. Global Drugs for Infectious Diseases Caused by Neisseria Gonorrhoeae Market Size Forecasted by Application (2027-2032) & (US$ Million) Table 25. Global Drugs for Infectious Diseases Caused by Neisseria Gonorrhoeae Market Size Share Forecasted by Application (2027-2032) Table 26. North America Drugs for Infectious Diseases Caused by Neisseria Gonorrhoeae Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 27. North America Drugs for Infectious Diseases Caused by Neisseria Gonorrhoeae Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 28. Europe Drugs for Infectious Diseases Caused by Neisseria Gonorrhoeae Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 29. Europe Drugs for Infectious Diseases Caused by Neisseria Gonorrhoeae Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 30. Asia-Pacific Drugs for Infectious Diseases Caused by Neisseria Gonorrhoeae Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 31. Asia-Pacific Drugs for Infectious Diseases Caused by Neisseria Gonorrhoeae Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 32. Latin America Drugs for Infectious Diseases Caused by Neisseria Gonorrhoeae Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 33. Latin America Drugs for Infectious Diseases Caused by Neisseria Gonorrhoeae Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 34. Middle East and Africa Drugs for Infectious Diseases Caused by Neisseria Gonorrhoeae Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 35. Middle East and Africa Drugs for Infectious Diseases Caused by Neisseria Gonorrhoeae Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 36. Drugs for Infectious Diseases Caused by Neisseria Gonorrhoeae Industry Trends Table 37. Drugs for Infectious Diseases Caused by Neisseria Gonorrhoeae Industry Drivers Table 38. Drugs for Infectious Diseases Caused by Neisseria Gonorrhoeae Industry Opportunities and Challenges Table 39. Drugs for Infectious Diseases Caused by Neisseria Gonorrhoeae Industry Restraints Table 40. Global Drugs for Infectious Diseases Caused by Neisseria Gonorrhoeae Revenue by Company (US$ Million) & (2021-2026) Table 41. Global Drugs for Infectious Diseases Caused by Neisseria Gonorrhoeae Revenue Market Share by Company (2021-2026) Table 42. Global Drugs for Infectious Diseases Caused by Neisseria Gonorrhoeae Industry Company Ranking, 2024 VS 2025 VS 2026 Table 43. Global Drugs for Infectious Diseases Caused by Neisseria Gonorrhoeae Key Company Headquarters & Area Served Table 44. Global Drugs for Infectious Diseases Caused by Neisseria Gonorrhoeae Company, Product Type & Application Table 45. Global Drugs for Infectious Diseases Caused by Neisseria Gonorrhoeae Company Commercialization Time Table 46. Global Company Market Concentration Ratio (CR5 and HHI) Table 47. Global Drugs for Infectious Diseases Caused by Neisseria Gonorrhoeae by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 48. Takeda Pharmaceutical Company Information Table 49. Takeda Pharmaceutical Business Overview Table 50. Takeda Pharmaceutical Drugs for Infectious Diseases Caused by Neisseria Gonorrhoeae Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 51. Takeda Pharmaceutical Drugs for Infectious Diseases Caused by Neisseria Gonorrhoeae Product Portfolio Table 52. Takeda Pharmaceutical Recent Development Table 53. CSPC Company Information Table 54. CSPC Business Overview Table 55. CSPC Drugs for Infectious Diseases Caused by Neisseria Gonorrhoeae Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 56. CSPC Drugs for Infectious Diseases Caused by Neisseria Gonorrhoeae Product Portfolio Table 57. CSPC Recent Development Table 58. Shenzhen Lijian Pharmaceutical Company Information Table 59. Shenzhen Lijian Pharmaceutical Business Overview Table 60. Shenzhen Lijian Pharmaceutical Drugs for Infectious Diseases Caused by Neisseria Gonorrhoeae Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 61. Shenzhen Lijian Pharmaceutical Drugs for Infectious Diseases Caused by Neisseria Gonorrhoeae Product Portfolio Table 62. Shenzhen Lijian Pharmaceutical Recent Development Table 63. Sanofi Company Information Table 64. Sanofi Business Overview Table 65. Sanofi Drugs for Infectious Diseases Caused by Neisseria Gonorrhoeae Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 66. Sanofi Drugs for Infectious Diseases Caused by Neisseria Gonorrhoeae Product Portfolio Table 67. Sanofi Recent Development Table 68. Merck & Co., Inc. (USA) Company Information Table 69. Merck & Co., Inc. (USA) Business Overview Table 70. Merck & Co., Inc. (USA) Drugs for Infectious Diseases Caused by Neisseria Gonorrhoeae Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 71. Merck & Co., Inc. (USA) Drugs for Infectious Diseases Caused by Neisseria Gonorrhoeae Product Portfolio Table 72. Merck & Co., Inc. (USA) Recent Development Table 73. Roche Company Information Table 74. Roche Business Overview Table 75. Roche Drugs for Infectious Diseases Caused by Neisseria Gonorrhoeae Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 76. Roche Drugs for Infectious Diseases Caused by Neisseria Gonorrhoeae Product Portfolio Table 77. Roche Recent Development Table 78. Pfizer Inc. (USA) Company Information Table 79. Pfizer Inc. (USA) Business Overview Table 80. Pfizer Inc. (USA) Drugs for Infectious Diseases Caused by Neisseria Gonorrhoeae Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 81. Pfizer Inc. (USA) Drugs for Infectious Diseases Caused by Neisseria Gonorrhoeae Product Portfolio Table 82. Pfizer Inc. (USA) Recent Development Table 83. NCPC Company Information Table 84. NCPC Business Overview Table 85. NCPC Drugs for Infectious Diseases Caused by Neisseria Gonorrhoeae Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 86. NCPC Drugs for Infectious Diseases Caused by Neisseria Gonorrhoeae Product Portfolio Table 87. NCPC Recent Development Table 88. Sinopharm Group Company Information Table 89. Sinopharm Group Business Overview Table 90. Sinopharm Group Drugs for Infectious Diseases Caused by Neisseria Gonorrhoeae Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 91. Sinopharm Group Drugs for Infectious Diseases Caused by Neisseria Gonorrhoeae Product Portfolio Table 92. Sinopharm Group Recent Development Table 93. GlaxoSmithKline plc (UK) Company Information Table 94. GlaxoSmithKline plc (UK) Business Overview Table 95. GlaxoSmithKline plc (UK) Drugs for Infectious Diseases Caused by Neisseria Gonorrhoeae Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 96. GlaxoSmithKline plc (UK) Drugs for Infectious Diseases Caused by Neisseria Gonorrhoeae Product Portfolio Table 97. GlaxoSmithKline plc (UK) Recent Development Table 98. Daiichi Sankyo Company Information Table 99. Daiichi Sankyo Business Overview Table 100. Daiichi Sankyo Drugs for Infectious Diseases Caused by Neisseria Gonorrhoeae Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 101. Daiichi Sankyo Drugs for Infectious Diseases Caused by Neisseria Gonorrhoeae Product Portfolio Table 102. Daiichi Sankyo Recent Development Table 103. Bayer Company Information Table 104. Bayer Business Overview Table 105. Bayer Drugs for Infectious Diseases Caused by Neisseria Gonorrhoeae Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 106. Bayer Drugs for Infectious Diseases Caused by Neisseria Gonorrhoeae Product Portfolio Table 107. Bayer Recent Development Table 108. AbbVie Company Information Table 109. AbbVie Business Overview Table 110. AbbVie Drugs for Infectious Diseases Caused by Neisseria Gonorrhoeae Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 111. AbbVie Drugs for Infectious Diseases Caused by Neisseria Gonorrhoeae Product Portfolio Table 112. AbbVie Recent Development Table 113. Sun Pharmaceutical Company Information Table 114. Sun Pharmaceutical Business Overview Table 115. Sun Pharmaceutical Drugs for Infectious Diseases Caused by Neisseria Gonorrhoeae Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 116. Sun Pharmaceutical Drugs for Infectious Diseases Caused by Neisseria Gonorrhoeae Product Portfolio Table 117. Sun Pharmaceutical Recent Development Table 118. Lupin Company Information Table 119. Lupin Business Overview Table 120. Lupin Drugs for Infectious Diseases Caused by Neisseria Gonorrhoeae Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 121. Lupin Drugs for Infectious Diseases Caused by Neisseria Gonorrhoeae Product Portfolio Table 122. Lupin Recent Development Table 123. Hikma Pharmaceuticals Company Information Table 124. Hikma Pharmaceuticals Business Overview Table 125. Hikma Pharmaceuticals Drugs for Infectious Diseases Caused by Neisseria Gonorrhoeae Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 126. Hikma Pharmaceuticals Drugs for Infectious Diseases Caused by Neisseria Gonorrhoeae Product Portfolio Table 127. Hikma Pharmaceuticals Recent Development Table 128. Dr. Reddy's Laboratories Company Information Table 129. Dr. Reddy's Laboratories Business Overview Table 130. Dr. Reddy's Laboratories Drugs for Infectious Diseases Caused by Neisseria Gonorrhoeae Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 131. Dr. Reddy's Laboratories Drugs for Infectious Diseases Caused by Neisseria Gonorrhoeae Product Portfolio Table 132. Dr. Reddy's Laboratories Recent Development Table 133. Cipla Company Information Table 134. Cipla Business Overview Table 135. Cipla Drugs for Infectious Diseases Caused by Neisseria Gonorrhoeae Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 136. Cipla Drugs for Infectious Diseases Caused by Neisseria Gonorrhoeae Product Portfolio Table 137. Cipla Recent Development Table 138. Celltrion Company Information Table 139. Celltrion Business Overview Table 140. Celltrion Drugs for Infectious Diseases Caused by Neisseria Gonorrhoeae Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 141. Celltrion Drugs for Infectious Diseases Caused by Neisseria Gonorrhoeae Product Portfolio Table 142. Celltrion Recent Development Table 143. Astellas Pharma Inc. (Japan) Company Information Table 144. Astellas Pharma Inc. (Japan) Business Overview Table 145. Astellas Pharma Inc. (Japan) Drugs for Infectious Diseases Caused by Neisseria Gonorrhoeae Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 146. Astellas Pharma Inc. (Japan) Drugs for Infectious Diseases Caused by Neisseria Gonorrhoeae Product Portfolio Table 147. Astellas Pharma Inc. (Japan) Recent Development Table 148. North America Drugs for Infectious Diseases Caused by Neisseria Gonorrhoeae Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 149. North America Drugs for Infectious Diseases Caused by Neisseria Gonorrhoeae Market Size by Country (2021-2026) & (US$ Million) Table 150. North America Drugs for Infectious Diseases Caused by Neisseria Gonorrhoeae Market Share by Country (2021-2026) Table 151. North America Drugs for Infectious Diseases Caused by Neisseria Gonorrhoeae Market Size Forecast by Country (2027-2032) & (US$ Million) Table 152. North America Drugs for Infectious Diseases Caused by Neisseria Gonorrhoeae Market Share Forecast by Country (2027-2032) Table 153. Europe Drugs for Infectious Diseases Caused by Neisseria Gonorrhoeae Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 154. Europe Drugs for Infectious Diseases Caused by Neisseria Gonorrhoeae Market Size by Country (2021-2026) & (US$ Million) Table 155. Europe Drugs for Infectious Diseases Caused by Neisseria Gonorrhoeae Market Share by Country (2021-2026) Table 156. Europe Drugs for Infectious Diseases Caused by Neisseria Gonorrhoeae Market Size Forecast by Country (2027-2032) & (US$ Million) Table 157. Europe Drugs for Infectious Diseases Caused by Neisseria Gonorrhoeae Market Share Forecast by Country (2027-2032) Table 158. Asia-Pacific Drugs for Infectious Diseases Caused by Neisseria Gonorrhoeae Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 159. Asia-Pacific Drugs for Infectious Diseases Caused by Neisseria Gonorrhoeae Market Size by Country (2021-2026) & (US$ Million) Table 160. Asia-Pacific Drugs for Infectious Diseases Caused by Neisseria Gonorrhoeae Market Share by Country (2021-2026) Table 161. Asia-Pacific Drugs for Infectious Diseases Caused by Neisseria Gonorrhoeae Market Size Forecast by Country (2027-2032) & (US$ Million) Table 162. Asia-Pacific Drugs for Infectious Diseases Caused by Neisseria Gonorrhoeae Market Share Forecast by Country (2027-2032) Table 163. Latin America Drugs for Infectious Diseases Caused by Neisseria Gonorrhoeae Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 164. Latin America Drugs for Infectious Diseases Caused by Neisseria Gonorrhoeae Market Size by Country (2021-2026) & (US$ Million) Table 165. Latin America Drugs for Infectious Diseases Caused by Neisseria Gonorrhoeae Market Share by Country (2021-2026) Table 166. Latin America Drugs for Infectious Diseases Caused by Neisseria Gonorrhoeae Market Size Forecast by Country (2027-2032) & (US$ Million) Table 167. Latin America Drugs for Infectious Diseases Caused by Neisseria Gonorrhoeae Market Share Forecast by Country (2027-2032) Table 168. Middle East & Africa Drugs for Infectious Diseases Caused by Neisseria Gonorrhoeae Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 169. Middle East & Africa Drugs for Infectious Diseases Caused by Neisseria Gonorrhoeae Market Size by Country (2021-2026) & (US$ Million) Table 170. Middle East & Africa Drugs for Infectious Diseases Caused by Neisseria Gonorrhoeae Market Share by Country (2021-2026) Table 171. Middle East & Africa Drugs for Infectious Diseases Caused by Neisseria Gonorrhoeae Market Size Forecast by Country (2027-2032) & (US$ Million) Table 172. Middle East & Africa Drugs for Infectious Diseases Caused by Neisseria Gonorrhoeae Market Share Forecast by Country (2027-2032) Table 173. Research Programs/Design for This Report Table 174. Authors List of This Report Table 175. Secondary Sources List of Figures Figure 1.List of Figures Figure 2. Drugs for Infectious Diseases Caused by Neisseria Gonorrhoeae Product Image Figure 3. Global Drugs for Infectious Diseases Caused by Neisseria Gonorrhoeae Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 4. Global Drugs for Infectious Diseases Caused by Neisseria Gonorrhoeae Market Size (2021-2032) & (US$ Million) Figure 5. Global Drugs for Infectious Diseases Caused by Neisseria Gonorrhoeae Market Share by Region: 2025 VS 2032 Figure 6. Global Drugs for Infectious Diseases Caused by Neisseria Gonorrhoeae Market Share by Region (2021-2032) Figure 7. North America Drugs for Infectious Diseases Caused by Neisseria Gonorrhoeae Market Size Growth Rate (2021-2032) & (US$ Million) Figure 8. Europe Drugs for Infectious Diseases Caused by Neisseria Gonorrhoeae Market Size Growth Rate (2021-2032) & (US$ Million) Figure 9. Asia-Pacific Drugs for Infectious Diseases Caused by Neisseria Gonorrhoeae Market Size Growth Rate (2021-2032) & (US$ Million) Figure 10. Latin America Drugs for Infectious Diseases Caused by Neisseria Gonorrhoeae Market Size Growth Rate (2021-2032) & (US$ Million) Figure 11. Middle East & Africa Drugs for Infectious Diseases Caused by Neisseria Gonorrhoeae Market Size Growth Rate (2021-2032) & (US$ Million) Figure 12. Ceftriaxone Image Figure 13. Global Ceftriaxone Market Size YoY Growth (2021-2032) & (US$ Million) Figure 14. Doxycycline Image Figure 15. Global Doxycycline Market Size YoY Growth (2021-2032) & (US$ Million) Figure 16. Other Image Figure 17. Global Other Market Size YoY Growth (2021-2032) & (US$ Million) Figure 18. Global Drugs for Infectious Diseases Caused by Neisseria Gonorrhoeae Market Size Overview by Type (2021-2032) & (US$ Million) Figure 19. Global Drugs for Infectious Diseases Caused by Neisseria Gonorrhoeae Market Share by Type 2025 VS 2032 Figure 20. North America Drugs for Infectious Diseases Caused by Neisseria Gonorrhoeae Market Size Share by Type (2021-2032) Figure 21. Europe Drugs for Infectious Diseases Caused by Neisseria Gonorrhoeae Market Size Share by Type (2021-2032) Figure 22. Asia-Pacific Drugs for Infectious Diseases Caused by Neisseria Gonorrhoeae Market Size Share by Type (2021-2032) Figure 23. Latin America Drugs for Infectious Diseases Caused by Neisseria Gonorrhoeae Market Size Share by Type (2021-2032) Figure 24. Middle East and Africa Drugs for Infectious Diseases Caused by Neisseria Gonorrhoeae Market Size Share by Type (2021-2032) Figure 25. Retail Pharmacy Image Figure 26. Global Retail Pharmacy Market Size YoY Growth (2021-2032) & (US$ Million) Figure 27. Hospital Image Figure 28. Global Hospital Market Size YoY Growth (2021-2032) & (US$ Million) Figure 29. Other Image Figure 30. Global Other Market Size YoY Growth (2021-2032) & (US$ Million) Figure 31. Global Drugs for Infectious Diseases Caused by Neisseria Gonorrhoeae Market Size Overview by Application (2021-2032) & (US$ Million) Figure 32. Global Drugs for Infectious Diseases Caused by Neisseria Gonorrhoeae Market Share by Application 2025 VS 2032 Figure 33. North America Drugs for Infectious Diseases Caused by Neisseria Gonorrhoeae Market Size Share by Application (2021-2032) Figure 34. Europe Drugs for Infectious Diseases Caused by Neisseria Gonorrhoeae Market Size Share by Application (2021-2032) Figure 35. Asia-Pacific Drugs for Infectious Diseases Caused by Neisseria Gonorrhoeae Market Size Share by Application (2021-2032) Figure 36. Latin America Drugs for Infectious Diseases Caused by Neisseria Gonorrhoeae Market Size Share by Application (2021-2032) Figure 37. Middle East and Africa Drugs for Infectious Diseases Caused by Neisseria Gonorrhoeae Market Size Share by Application (2021-2032) Figure 38. Global Top 5 and 10 Drugs for Infectious Diseases Caused by Neisseria Gonorrhoeae Players Market Share by Revenue in 2025 Figure 39. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 40. North America Drugs for Infectious Diseases Caused by Neisseria Gonorrhoeae Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 41. North America Drugs for Infectious Diseases Caused by Neisseria Gonorrhoeae Market Share by Country: 2021 VS 2025 VS 2032 Figure 42. North America Drugs for Infectious Diseases Caused by Neisseria Gonorrhoeae Market Share by Country (2021-2032) Figure 43. Europe Drugs for Infectious Diseases Caused by Neisseria Gonorrhoeae Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 44. Europe Drugs for Infectious Diseases Caused by Neisseria Gonorrhoeae Market Share by Country: 2021 VS 2025 VS 2032 Figure 45. Europe Drugs for Infectious Diseases Caused by Neisseria Gonorrhoeae Market Share by Country (2021-2032) Figure 46. Asia-Pacific Drugs for Infectious Diseases Caused by Neisseria Gonorrhoeae Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 47. Asia-Pacific Drugs for Infectious Diseases Caused by Neisseria Gonorrhoeae Market Share by Country: 2021 VS 2025 VS 2032 Figure 48. Asia-Pacific Drugs for Infectious Diseases Caused by Neisseria Gonorrhoeae Market Share by Country (2021-2032) Figure 49. Latin America Drugs for Infectious Diseases Caused by Neisseria Gonorrhoeae Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 50. Latin America Drugs for Infectious Diseases Caused by Neisseria Gonorrhoeae Market Share by Country: 2021 VS 2025 VS 2032 Figure 51. Latin America Drugs for Infectious Diseases Caused by Neisseria Gonorrhoeae Market Share by Country (2021-2032) Figure 52. Middle East & Africa Drugs for Infectious Diseases Caused by Neisseria Gonorrhoeae Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 53. Middle East & Africa Drugs for Infectious Diseases Caused by Neisseria Gonorrhoeae Market Share by Country: 2021 VS 2025 VS 2032 Figure 54. Middle East & Africa Drugs for Infectious Diseases Caused by Neisseria Gonorrhoeae Market Share by Country (2021-2032) Figure 55. Years Considered Figure 56. Research Process Figure 57. Key Executives Interviewed

Scope & coverage.

Types
  • Ceftriaxone
  • Doxycycline
  • Other
Applications
  • Retail Pharmacy
  • Hospital
  • Other
Companies covered
  • Takeda Pharmaceutical
  • CSPC
  • Shenzhen Lijian Pharmaceutical
  • Sanofi
  • Merck & Co., Inc. (USA)
  • Roche
  • Pfizer Inc. (USA)
  • NCPC
  • Sinopharm Group
  • GlaxoSmithKline plc (UK)
  • Daiichi Sankyo
  • Bayer
  • AbbVie
  • Sun Pharmaceutical
  • Lupin
  • Hikma Pharmaceuticals
  • Dr. Reddy's Laboratories
  • Cipla
  • Celltrion
  • Astellas Pharma Inc. (Japan)

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.3 Global Drugs for Infectious Diseases Caused by Neisseria Gonorrhoeae Market Size Overview by Region 2021 VS 2025 VS 2032
  4. 1.4 Global Drugs for Infectious Diseases Caused by Neisseria Gonorrhoeae Market Size by Region (2021-2032)
  5. 1.4.1 Global Drugs for Infectious Diseases Caused by Neisseria Gonorrhoeae Market Size by Region (2021-2026)
  6. 1.4.2 Global Drugs for Infectious Diseases Caused by Neisseria Gonorrhoeae Market Size by Region (2027-2032)
  7. 1.5 Key Regions Drugs for Infectious Diseases Caused by Neisseria Gonorrhoeae Market Size (2021-2032)
  8. 1.5.1 North America Drugs for Infectious Diseases Caused by Neisseria Gonorrhoeae Market Size Growth Rate (2021-2032)
  9. 1.5.2 Europe Drugs for Infectious Diseases Caused by Neisseria Gonorrhoeae Market Size Growth Rate (2021-2032)
  10. 1.5.3 Asia-Pacific Drugs for Infectious Diseases Caused by Neisseria Gonorrhoeae Market Size Growth Rate (2021-2032)
  11. 1.5.4 South America Drugs for Infectious Diseases Caused by Neisseria Gonorrhoeae Market Size Growth Rate (2021-2032)
  12. 1.5.5 Middle East & Africa Drugs for Infectious Diseases Caused by Neisseria Gonorrhoeae Market Size Growth Rate (2021-2032)
2 Drugs for Infectious Diseases Caused by Neisseria Gonorrhoeae Market by Type
  1. 2.1 Type Introduction
  2. 2.1.1 Ceftriaxone
  3. 2.1.2 Doxycycline
  4. 2.1.3 Other
  5. 2.2 Global Drugs for Infectious Diseases Caused by Neisseria Gonorrhoeae Market Size by Type
  6. 2.2.1 Global Drugs for Infectious Diseases Caused by Neisseria Gonorrhoeae Market Size Overview by Type (2021-2032)
  7. 2.2.2 Global Drugs for Infectious Diseases Caused by Neisseria Gonorrhoeae Historic Market Size Review by Type (2021-2026)
  8. 2.2.3 Global Drugs for Infectious Diseases Caused by Neisseria Gonorrhoeae Market Size Forecasted by Type (2027-2032)
  9. 2.3 Global Drugs for Infectious Diseases Caused by Neisseria Gonorrhoeae Market Size by Regions
  10. 2.3.1 North America Drugs for Infectious Diseases Caused by Neisseria Gonorrhoeae Market Size Breakdown by Type (2021-2026)
  11. 2.3.2 Europe Drugs for Infectious Diseases Caused by Neisseria Gonorrhoeae Market Size Breakdown by Type (2021-2026)
  12. 2.3.3 Asia-Pacific Drugs for Infectious Diseases Caused by Neisseria Gonorrhoeae Market Size Breakdown by Type (2021-2026)
  13. 2.3.4 South America Drugs for Infectious Diseases Caused by Neisseria Gonorrhoeae Market Size Breakdown by Type (2021-2026)
  14. 2.3.5 Middle East and Africa Drugs for Infectious Diseases Caused by Neisseria Gonorrhoeae Market Size Breakdown by Type (2021-2026)
3 Drugs for Infectious Diseases Caused by Neisseria Gonorrhoeae Market by Application
  1. 3.1 Type Introduction
  2. 3.1.1 Retail Pharmacy
  3. 3.1.2 Hospital
  4. 3.1.3 Other
  5. 3.2 Global Drugs for Infectious Diseases Caused by Neisseria Gonorrhoeae Market Size by Application
  6. 3.2.1 Global Drugs for Infectious Diseases Caused by Neisseria Gonorrhoeae Market Size Overview by Application (2021-2032)
  7. 3.2.2 Global Drugs for Infectious Diseases Caused by Neisseria Gonorrhoeae Historic Market Size Review by Application (2021-2026)
  8. 3.2.3 Global Drugs for Infectious Diseases Caused by Neisseria Gonorrhoeae Market Size Forecasted by Application (2027-2032)
  9. 3.3 Global Drugs for Infectious Diseases Caused by Neisseria Gonorrhoeae Market Size by Regions
  10. 3.3.1 North America Drugs for Infectious Diseases Caused by Neisseria Gonorrhoeae Market Size Breakdown by Application (2021-2026)
  11. 3.3.2 Europe Drugs for Infectious Diseases Caused by Neisseria Gonorrhoeae Market Size Breakdown by Application (2021-2026)
  12. 3.3.3 Asia-Pacific Drugs for Infectious Diseases Caused by Neisseria Gonorrhoeae Market Size Breakdown by Application (2021-2026)
  13. 3.3.4 South America Drugs for Infectious Diseases Caused by Neisseria Gonorrhoeae Market Size Breakdown by Application (2021-2026)
  14. 3.3.5 Middle East and Africa Drugs for Infectious Diseases Caused by Neisseria Gonorrhoeae Market Size Breakdown by Application (2021-2026)
4 Global Market Dynamics
  1. 4.1 Drugs for Infectious Diseases Caused by Neisseria Gonorrhoeae Industry Trends
  2. 4.2 Drugs for Infectious Diseases Caused by Neisseria Gonorrhoeae Industry Drivers
  3. 4.3 Drugs for Infectious Diseases Caused by Neisseria Gonorrhoeae Industry Opportunities and Challenges
  4. 4.4 Drugs for Infectious Diseases Caused by Neisseria Gonorrhoeae Industry Restraints
5 Competitive Insights by Company
  1. 5.1 Global Top Players by Drugs for Infectious Diseases Caused by Neisseria Gonorrhoeae Revenue (2021-2026)
  2. 5.2 Global Drugs for Infectious Diseases Caused by Neisseria Gonorrhoeae Industry Company Ranking, 2024 VS 2025 VS 2026
  3. 5.3 Global Drugs for Infectious Diseases Caused by Neisseria Gonorrhoeae Key Company Headquarters & Area Served
  4. 5.4 Global Drugs for Infectious Diseases Caused by Neisseria Gonorrhoeae Company, Product Type & Application
  5. 5.5 Global Drugs for Infectious Diseases Caused by Neisseria Gonorrhoeae Company Commercialization Time
  6. 5.6 Market Competitive Analysis
  7. 5.6.1 Global Drugs for Infectious Diseases Caused by Neisseria Gonorrhoeae Market CR5 and HHI
  8. 5.6.2 Global Top 5 and 10 Drugs for Infectious Diseases Caused by Neisseria Gonorrhoeae Players Market Share by Revenue in 2025
  9. 5.6.3 2025 Drugs for Infectious Diseases Caused by Neisseria Gonorrhoeae Tier 1, Tier 2, and Tier 3
6 Company Profiles
  1. 6.1 Takeda Pharmaceutical
  2. 6.1.1 Takeda Pharmaceutical Company Information
  3. 6.1.2 Takeda Pharmaceutical Business Overview
  4. 6.1.3 Takeda Pharmaceutical Drugs for Infectious Diseases Caused by Neisseria Gonorrhoeae Revenue, Global Share and Gross Margin (2021-2026)
  5. 6.1.4 Takeda Pharmaceutical Drugs for Infectious Diseases Caused by Neisseria Gonorrhoeae Product Portfolio
  6. 6.1.5 Takeda Pharmaceutical Recent Developments
  7. 6.2 CSPC
  8. 6.2.1 CSPC Company Information
  9. 6.2.2 CSPC Business Overview
  10. 6.2.3 CSPC Drugs for Infectious Diseases Caused by Neisseria Gonorrhoeae Revenue, Global Share and Gross Margin (2021-2026)
  11. 6.2.4 CSPC Drugs for Infectious Diseases Caused by Neisseria Gonorrhoeae Product Portfolio
  12. 6.2.5 CSPC Recent Developments
  13. 6.3 Shenzhen Lijian Pharmaceutical
  14. 6.3.1 Shenzhen Lijian Pharmaceutical Company Information
  15. 6.3.2 Shenzhen Lijian Pharmaceutical Business Overview
  16. 6.3.3 Shenzhen Lijian Pharmaceutical Drugs for Infectious Diseases Caused by Neisseria Gonorrhoeae Revenue, Global Share and Gross Margin (2021-2026)
  17. 6.3.4 Shenzhen Lijian Pharmaceutical Drugs for Infectious Diseases Caused by Neisseria Gonorrhoeae Product Portfolio
  18. 6.3.5 Shenzhen Lijian Pharmaceutical Recent Developments
  19. 6.4 Sanofi
  20. 6.4.1 Sanofi Company Information
  21. 6.4.2 Sanofi Business Overview
  22. 6.4.3 Sanofi Drugs for Infectious Diseases Caused by Neisseria Gonorrhoeae Revenue, Global Share and Gross Margin (2021-2026)
  23. 6.4.4 Sanofi Drugs for Infectious Diseases Caused by Neisseria Gonorrhoeae Product Portfolio
  24. 6.4.5 Sanofi Recent Developments
  25. 6.5 Merck & Co., Inc. (USA)
  26. 6.5.1 Merck & Co., Inc. (USA) Company Information
  27. 6.5.2 Merck & Co., Inc. (USA) Business Overview
  28. 6.5.3 Merck & Co., Inc. (USA) Drugs for Infectious Diseases Caused by Neisseria Gonorrhoeae Revenue, Global Share and Gross Margin (2021-2026)
  29. 6.5.4 Merck & Co., Inc. (USA) Drugs for Infectious Diseases Caused by Neisseria Gonorrhoeae Product Portfolio
  30. 6.5.5 Merck & Co., Inc. (USA) Recent Developments
  31. 6.6 Roche
  32. 6.6.1 Roche Company Information
  33. 6.6.2 Roche Business Overview
  34. 6.6.3 Roche Drugs for Infectious Diseases Caused by Neisseria Gonorrhoeae Revenue, Global Share and Gross Margin (2021-2026)
  35. 6.6.4 Roche Drugs for Infectious Diseases Caused by Neisseria Gonorrhoeae Product Portfolio
  36. 6.6.5 Roche Recent Developments
  37. 6.7 Pfizer Inc. (USA)
  38. 6.7.1 Pfizer Inc. (USA) Company Information
  39. 6.7.2 Pfizer Inc. (USA) Business Overview
  40. 6.7.3 Pfizer Inc. (USA) Drugs for Infectious Diseases Caused by Neisseria Gonorrhoeae Revenue, Global Share and Gross Margin (2021-2026)
  41. 6.7.4 Pfizer Inc. (USA) Drugs for Infectious Diseases Caused by Neisseria Gonorrhoeae Product Portfolio
  42. 6.7.5 Pfizer Inc. (USA) Recent Developments
  43. 6.8 NCPC
  44. 6.8.1 NCPC Company Information
  45. 6.8.2 NCPC Business Overview
  46. 6.8.3 NCPC Drugs for Infectious Diseases Caused by Neisseria Gonorrhoeae Revenue, Global Share and Gross Margin (2021-2026)
  47. 6.8.4 NCPC Drugs for Infectious Diseases Caused by Neisseria Gonorrhoeae Product Portfolio
  48. 6.8.5 NCPC Recent Developments
  49. 6.9 Sinopharm Group
  50. 6.9.1 Sinopharm Group Company Information
  51. 6.9.2 Sinopharm Group Business Overview
  52. 6.9.3 Sinopharm Group Drugs for Infectious Diseases Caused by Neisseria Gonorrhoeae Revenue, Global Share and Gross Margin (2021-2026)
  53. 6.9.4 Sinopharm Group Drugs for Infectious Diseases Caused by Neisseria Gonorrhoeae Product Portfolio
  54. 6.9.5 Sinopharm Group Recent Developments
  55. 6.10 GlaxoSmithKline plc (UK)
  56. 6.10.1 GlaxoSmithKline plc (UK) Company Information
  57. 6.10.2 GlaxoSmithKline plc (UK) Business Overview
  58. 6.10.3 GlaxoSmithKline plc (UK) Drugs for Infectious Diseases Caused by Neisseria Gonorrhoeae Revenue, Global Share and Gross Margin (2021-2026)
  59. 6.10.4 GlaxoSmithKline plc (UK) Drugs for Infectious Diseases Caused by Neisseria Gonorrhoeae Product Portfolio
  60. 6.10.5 GlaxoSmithKline plc (UK) Recent Developments
  61. 6.11 Daiichi Sankyo
  62. 6.11.1 Daiichi Sankyo Company Information
  63. 6.11.2 Daiichi Sankyo Business Overview
  64. 6.11.3 Daiichi Sankyo Drugs for Infectious Diseases Caused by Neisseria Gonorrhoeae Revenue, Global Share and Gross Margin (2021-2026)
  65. 6.11.4 Daiichi Sankyo Drugs for Infectious Diseases Caused by Neisseria Gonorrhoeae Product Portfolio
  66. 6.11.5 Daiichi Sankyo Recent Developments
  67. 6.12 Bayer
  68. 6.12.1 Bayer Company Information
  69. 6.12.2 Bayer Business Overview
  70. 6.12.3 Bayer Drugs for Infectious Diseases Caused by Neisseria Gonorrhoeae Revenue, Global Share and Gross Margin (2021-2026)
  71. 6.12.4 Bayer Drugs for Infectious Diseases Caused by Neisseria Gonorrhoeae Product Portfolio
  72. 6.12.5 Bayer Recent Developments
  73. 6.13 AbbVie
  74. 6.13.1 AbbVie Company Information
  75. 6.13.2 AbbVie Business Overview
  76. 6.13.3 AbbVie Drugs for Infectious Diseases Caused by Neisseria Gonorrhoeae Revenue, Global Share and Gross Margin (2021-2026)
  77. 6.13.4 AbbVie Drugs for Infectious Diseases Caused by Neisseria Gonorrhoeae Product Portfolio
  78. 6.13.5 AbbVie Recent Developments
  79. 6.14 Sun Pharmaceutical
  80. 6.14.1 Sun Pharmaceutical Company Information
  81. 6.14.2 Sun Pharmaceutical Business Overview
  82. 6.14.3 Sun Pharmaceutical Drugs for Infectious Diseases Caused by Neisseria Gonorrhoeae Revenue, Global Share and Gross Margin (2021-2026)
  83. 6.14.4 Sun Pharmaceutical Drugs for Infectious Diseases Caused by Neisseria Gonorrhoeae Product Portfolio
  84. 6.14.5 Sun Pharmaceutical Recent Developments
  85. 6.15 Lupin
  86. 6.15.1 Lupin Company Information
  87. 6.15.2 Lupin Business Overview
  88. 6.15.3 Lupin Drugs for Infectious Diseases Caused by Neisseria Gonorrhoeae Revenue, Global Share and Gross Margin (2021-2026)
  89. 6.15.4 Lupin Drugs for Infectious Diseases Caused by Neisseria Gonorrhoeae Product Portfolio
  90. 6.15.5 Lupin Recent Developments
  91. 6.16 Hikma Pharmaceuticals
  92. 6.16.1 Hikma Pharmaceuticals Company Information
  93. 6.16.2 Hikma Pharmaceuticals Business Overview
  94. 6.16.3 Hikma Pharmaceuticals Drugs for Infectious Diseases Caused by Neisseria Gonorrhoeae Revenue, Global Share and Gross Margin (2021-2026)
  95. 6.16.4 Hikma Pharmaceuticals Drugs for Infectious Diseases Caused by Neisseria Gonorrhoeae Product Portfolio
  96. 6.16.5 Hikma Pharmaceuticals Recent Developments
  97. 6.17 Dr. Reddy's Laboratories
  98. 6.17.1 Dr. Reddy's Laboratories Company Information
  99. 6.17.2 Dr. Reddy's Laboratories Business Overview
  100. 6.17.3 Dr. Reddy's Laboratories Drugs for Infectious Diseases Caused by Neisseria Gonorrhoeae Revenue, Global Share and Gross Margin (2021-2026)
  101. 6.17.4 Dr. Reddy's Laboratories Drugs for Infectious Diseases Caused by Neisseria Gonorrhoeae Product Portfolio
  102. 6.17.5 Dr. Reddy's Laboratories Recent Developments
  103. 6.18 Cipla
  104. 6.18.1 Cipla Company Information
  105. 6.18.2 Cipla Business Overview
  106. 6.18.3 Cipla Drugs for Infectious Diseases Caused by Neisseria Gonorrhoeae Revenue, Global Share and Gross Margin (2021-2026)
  107. 6.18.4 Cipla Drugs for Infectious Diseases Caused by Neisseria Gonorrhoeae Product Portfolio
  108. 6.18.5 Cipla Recent Developments
  109. 6.19 Celltrion
  110. 6.19.1 Celltrion Company Information
  111. 6.19.2 Celltrion Business Overview
  112. 6.19.3 Celltrion Drugs for Infectious Diseases Caused by Neisseria Gonorrhoeae Revenue, Global Share and Gross Margin (2021-2026)
  113. 6.19.4 Celltrion Drugs for Infectious Diseases Caused by Neisseria Gonorrhoeae Product Portfolio
  114. 6.19.5 Celltrion Recent Developments
  115. 6.20 Astellas Pharma Inc. (Japan)
  116. 6.20.1 Astellas Pharma Inc. (Japan) Company Information
  117. 6.20.2 Astellas Pharma Inc. (Japan) Business Overview
  118. 6.20.3 Astellas Pharma Inc. (Japan) Drugs for Infectious Diseases Caused by Neisseria Gonorrhoeae Revenue, Global Share and Gross Margin (2021-2026)
  119. 6.20.4 Astellas Pharma Inc. (Japan) Drugs for Infectious Diseases Caused by Neisseria Gonorrhoeae Product Portfolio
  120. 6.20.5 Astellas Pharma Inc. (Japan) Recent Developments
7 North America
  1. 7.1 North America Drugs for Infectious Diseases Caused by Neisseria Gonorrhoeae Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 7.2 North America Drugs for Infectious Diseases Caused by Neisseria Gonorrhoeae Market Size by Country (2021-2026)
  3. 7.3 North America Drugs for Infectious Diseases Caused by Neisseria Gonorrhoeae Market Size Forecast by Country (2027-2032)
8 Europe
  1. 8.1 Europe Drugs for Infectious Diseases Caused by Neisseria Gonorrhoeae Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 8.2 Europe Drugs for Infectious Diseases Caused by Neisseria Gonorrhoeae Market Size by Country (2021-2026)
  3. 8.3 Europe Drugs for Infectious Diseases Caused by Neisseria Gonorrhoeae Market Size Forecast by Country (2027-2032)
9 Asia-Pacific
  1. 9.1 Asia-Pacific Drugs for Infectious Diseases Caused by Neisseria Gonorrhoeae Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 9.2 Asia-Pacific Drugs for Infectious Diseases Caused by Neisseria Gonorrhoeae Market Size by Country (2021-2026)
  3. 9.3 Asia-Pacific Drugs for Infectious Diseases Caused by Neisseria Gonorrhoeae Market Size Forecast by Country (2027-2032)
10 South America
  1. 10.1 South America Drugs for Infectious Diseases Caused by Neisseria Gonorrhoeae Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 10.2 South America Drugs for Infectious Diseases Caused by Neisseria Gonorrhoeae Market Size by Country (2021-2026)
  3. 10.3 South America Drugs for Infectious Diseases Caused by Neisseria Gonorrhoeae Market Size Forecast by Country (2027-2032)
11 Middle East & Africa
  1. 11.1 Middle East & Africa Drugs for Infectious Diseases Caused by Neisseria Gonorrhoeae Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 11.2 Middle East & Africa Drugs for Infectious Diseases Caused by Neisseria Gonorrhoeae Market Size by Country (2021-2026)
  3. 11.3 Middle East & Africa Drugs for Infectious Diseases Caused by Neisseria Gonorrhoeae Market Size Forecast by Country (2027-2032)
12 Concluding Insights
    13 Appendix
    1. 13.1 Reasons for Doing This Study
    2. 13.2 Research Methodology
    3. 13.3 Research Process
    4. 13.4 Authors List of This Report
    5. 13.5 Data Source
    6. 13.5.1 Secondary Sources
    7. 13.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst